We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleIn vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.AuthorsLu, Jingning; Yue, Jun; Wu, Jing; Luo, Rusong; Hu, Zhidong; Li, Jianrong; Bai, Yun; Tang, Zhijiao; Xian, Qiaoyang; Zhang, Xuelian; Wang, HonghaiAbstractDue to the long duration of treatment and the emergence of multidrug-resistant strains, new antitubercular agents are urgently needed. I2906, as a novel lead, was screened and tested for efficacy in vitro and in vivo.PublicationPharmacology, 2010, Vol 85, Issue 6, p365ISSN1423-0313Publication typeJournal ArticleDOI10.1159/000299795